Astrana Health, Inc. (ASTH) stock
Close on Nov 11, 2026Market cap $1.84BP/E 30.8Yield –
Astrana Health, Inc. grew revenue 35.1% to $3.91B over the twelve months to Sep 30, 2026. Operating income rose 99.0% to $121.12M, moving the operating margin from 2.1% to 3.1%. Free cash flow was $99.42M, up 2.5% from a year earlier. At the latest close the market valued the company at $1.84B, 30.8 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.84B
- P/E ratio
- 30.8
- Price to sales
- 0.47
- Price to book
- 2.14
- Dividend yield
- –
- Free cash flow yield
- 5.41%
Fundamentals
- Revenue
- $3.91B
- Net income
- $53.13M
- EPS, diluted
- $1.07
- Free cash flow
- $99.42M
- Book value per share
- $17.16
- Diluted shares
- 50M
Trading
- Next earnings
- Mar 1, 2027 (estimated, before the open)
- Previous close
- $32.18
- Open
- $32.22
- Day's range
- $32.15 – $33.28
- Volume
- 285,385
- Average volume (20 days)
- 360,778
- Index membership
- S&P SmallCap 600 (since Aug 2021), Russell 2000, Russell 3000
- Beta (5 years)
- 1.20
- 52-week range
- $18.08 – $51.60
- RSI (14 days)
- 37.1
- Volatility (1 year)
- 62.8%
- Relative volume
- 0.65×
- WACC
- 8.8%
On 1 of our idea list: Institutions accumulating
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ASTH | S&P 500 | Difference | ASTH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -12.3% | -2.4% | −9.9 pts | ||
| 3 months | -4.5% | -1.2% | −3.3 pts | ||
| Year to date | +32.8% | +12.3% | +20.5 pts | ||
| 1 year | +38.4% | +12.4% | +26.0 pts | ||
| 3 years | +9.1% | +78.8% | −69.7 pts | +2.9% | +21.4% |
| 5 years | -68.6% | +75.2% | −143.8 pts | -20.7% | +11.9% |
| 10 years | +632.0% | +311.1% | +320.9 pts | +22.0% | +15.2% |
Fourteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Astrana Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
About Astrana Health
Services-Management Consulting Services
Astrana Health, Inc. is a healthcare management and care delivery company operating primarily through three core segments: Care Delivery, Care Enablement, and Care Partners. The company provides healthcare patient services, management services, and capitated healthcare arrangements. Through its network relationships, management contracts, and affiliated independent physician associations, it coordinates and delivers medical care. Its primary customers and payors comprise patients and members enrolled in Medicare, Medicaid, and commercial health plans, alongside affiliated physicians and medical groups.
Company profile, executives and historyAstrana Health stock: common questions
What is Astrana Health's stock price?
ASTH closed at $32.94 on Nov 11, 2026, up 2.36% on the day. Over the past 52 weeks it traded between $18.08 and $51.60.
What is Astrana Health's market cap?
Astrana Health was worth $1.84B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ASTH's P/E ratio?
ASTH trades at 30.8 times earnings, based on diluted earnings per share of $1.07 over the twelve months to Sep 30, 2026.
How much revenue does Astrana Health make?
Astrana Health reported revenue of $3.91B for the twelve months to Sep 30, 2026, up 35.1% from a year earlier.
Does Astrana Health pay a dividend?
No. Astrana Health has not paid a cash dividend over the last twelve months.
When does Astrana Health report earnings next?
Astrana Health is expected to report Q4 FY2026 results on Mar 1, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has ASTH stock performed over the past year?
Including dividends, ASTH returned +38.4% over the past year, against +12.4% for the S&P 500.
How many ASTH shares are sold short?
3M shares were sold short at the latest FINRA report, 7.75% of the float, or 12.3 days of average trading volume.
Who are Astrana Health's competitors?
Companies most similar to Astrana Health by business, industry and size include EVH, HURN, FCN, G, ICFI.
See a number that looks wrong?